Shuo Sheng

发表

Ellagic acid produces neuroprotection against LPS-induced dopamine neurotoxicity via the inhibition of microglial NLRP3 inflammasome activation

Xuedong He, Feng Zhang, Qiu-yu Yang, 2019 .

New hope for Parkinson's disease treatment: Targeting gut microbiota

Feng Zhang, Hong-Xia Fan, Shuo Sheng, 2022, CNS neuroscience & therapeutics.

Insights into the roles of bacterial infection and antibiotics in Parkinson’s disease

Shuo Zhao, Shuo Sheng, Feng Zhang, 2022, Frontiers in Cellular and Infection Microbiology.

Ellagic acid protects dopamine neurons from rotenone‐induced neurotoxicity via activation of Nrf2 signalling

Yi-zheng Wei, Jing-jie Li, Dai‐di Li, 2020, Journal of cellular and molecular medicine.

Ellagic acid protects from rotenone-induced dopaminergic neuronal damage via activation of Nrf2 signaling in astroglia

Zhu Guofu, Yi-zheng Wei, Jing-jie Li, 2020, SSRN Electronic Journal.

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats

Hong Fan, Xiao-xian Li, Jing-jie Li, 2021, Frontiers in Immunology.

Heat‐killed Lactobacillus murinus confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome

Jing-jie Li, Hong-Xia Fan, Dai‐di Li, 2022, Bioengineering & translational medicine.

Effects of levodopa on gut bacterial antibiotic resistance in Parkinson’s disease rat

Shuo Zhao, Xianwei Li, Shuo Sheng, 2023, Frontiers in Aging Neuroscience.

Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia

Xue-mei He, Jing-jie Li, Shuo Sheng, 2020, Oxidative medicine and cellular longevity.

Relationship Between Gut Bacteria and Levodopa Metabolism

Shuo Sheng, Feng Zhang, Kaifei Xu, 2022, Current neuropharmacology.